USA flag logo/image

An Official Website of the United States Government

Tools for Targeted Delivery of DNA into Mammalian Cells

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
70766
Program Year/Program:
2004 / SBIR
Agency Tracking Number:
RR018437
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Alpha Universe LLC
1202 Ann Street Madison, WI 53713-2410
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2004
Title: Tools for Targeted Delivery of DNA into Mammalian Cells
Agency: HHS
Contract: 1R43RR018437-01A1
Award Amount: $144,888.00
 

Abstract:

DESCRIPTION (provided by applicant): Viral vectors are the most efficient tools currently available for genetic modification of mammalian cells in vitro and in vivo. However, because protocols for the incorporation of DNA of interest into viral particles are rather lengthy and cumbersome, these vectors have not been extensively used in the area of cell biology. In the area of genetic therapy these vectors remain unchallenged tools, but they are expensive to produce, suffer from the inability to target only chosen types of cells and their application could be associated with substantial health risks. On the contrary, bacteriophage lambda-derived vectors are easy and safe to use. They have a substantial capacity and could be reproducibly obtained in high quantities. For years bacteriophage lambda-based vectors have been used as versatile tools for the delivery of foreign DNA into bacterial, but not into mammalian cells. The purpose of the current proposal is to identify ways to convert bacteriophage lambda from being a general toot in molecular biology to a general toot for cell biology. We intend to prove that provided with means to recognize specific receptors on the surface of mammalian cells and penetrate through the cell membrane, bacteriophage lambda particles will be able to deliver extended DNA sequences into mammalian cells. During Phase I proof of the concept will be achieved through the delivery of DNA capable of directing the synthesis of green fluorescent protein into mammalian cells. During Phase II efforts will be directed towards optimization of such important processes as receptor recognition, membrane penetration, release of DNA from a phage capsid and transport of DNA into the cell nucleus. As a result of these efforts we expect to create a new tool that will allow for efficient shuttling of DNA constructs (including combinatorial libraries) from E. coil into mammalian cells. Also, we expect to lay a foundation for construction of customized bacteriophage-based DNA delivery systems suitable for genetic therapy applications.

Principal Investigator:

Alexey G. Zdanovsky
6086610861
ALEXEYZD@TDS.NET

Business Contact:

Alexey Zdanovsky
6086610861
ALEXEYZD@MAILBAG.COM
Small Business Information at Submission:

ALPHA UNIVERSE, LLC
ALPHA UNIVERSE, LLC 1202 ANN ST MADISON, WI 53713

EIN/Tax ID: 320102198
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No